Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Kuyat v. BioMimetic Therapeutics, Inc. et al
Case Number:
3:11-cv-00653
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
January 11, 2013
BioMimetic Triumphs Over Investors' Fraud Class Action
A Tennessee federal judge on Thursday tossed a shareholder class action against BioMimetic Therapeutics Inc. and its two top executives, ruling that the plaintiffs had failed to prove the orthopedics company lied about the progress of approval for a bone injury treatment that decimated its stock price.
-
July 07, 2011
Investor Hits BioMimetic With Fraud Action
A BioMimetic Therapeutics Inc. investor filed a securities class action Wednesday in Tennessee accusing the medical device maker of lying about the progress of approval for a new bone injury treatment, causing its stock price to plummet when a safety panel questioned the product's potential to cause cancer.